Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Narsoplimab

😃Good
Catalog No. T76870Cas No. 2108782-45-0
Alias OMS 721

Narsoplimab (OMS 721) is a selective whole-human immunoglobulin gamma-4 (IgG4) monoclonal antibody and a mannan-binding lectin-associated serine protease-2 (MASP-2) inhibitor that binds MASP-2 to prevent lectin pathway activation and inhibit the agglutinin pathway. It is used to study diseases associated with hematopoietic stem cell transplantation in adults.

Narsoplimab

Narsoplimab

😃Good
Catalog No. T76870Alias OMS 721Cas No. 2108782-45-0
Narsoplimab (OMS 721) is a selective whole-human immunoglobulin gamma-4 (IgG4) monoclonal antibody and a mannan-binding lectin-associated serine protease-2 (MASP-2) inhibitor that binds MASP-2 to prevent lectin pathway activation and inhibit the agglutinin pathway. It is used to study diseases associated with hematopoietic stem cell transplantation in adults.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$263In StockIn Stock
5 mg$695In StockIn Stock
10 mg$1,070-In Stock
25 mg$1,590-In Stock
50 mg$2,150-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.56% (SEC-HPLC)
Contact us for more batch information

Product Introduction

Bioactivity
Description
Narsoplimab (OMS 721) is a selective whole-human immunoglobulin gamma-4 (IgG4) monoclonal antibody and a mannan-binding lectin-associated serine protease-2 (MASP-2) inhibitor that binds MASP-2 to prevent lectin pathway activation and inhibit the agglutinin pathway. It is used to study diseases associated with hematopoietic stem cell transplantation in adults.
In vitro
Narsoplimab (100 nM; 3 h; Vero E6 cells and Vero E6 cells with SARS-CoV-2) inhibits N protein-enhanced MASP-2 deposition[1].
In vivo
Narsoplimab (10 mg/kg; i.v.; WT and Masp2-/- (KO) mice) reduced lymphocyte percentage (Lym%) and increased neutrophil percentage (Neu%)[1].
SynonymsOMS 721
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetMASP2
Chemical Properties
Molecular Weight143.1 kDa
Cas No.2108782-45-0
ColorTransparent
AppearanceLiquid
Antibody Information
IsotypeHuman IgG4SP lambda2
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Narsoplimab | purchase Narsoplimab | Narsoplimab cost | order Narsoplimab | Narsoplimab in vivo | Narsoplimab in vitro | Narsoplimab molecular weight